TEL AVIV—Early data from Israel suggests a booster shot of Pfizer Inc.’s Covid-19 vaccine can significantly improve immunity in those aged 60 and above, as the U.S. and other countries plan additional doses to increase protection against the highly infectious Delta variant.
Israel was one of the first countries late last month to authorize a third Pfizer dose for the elderly who were fully vaccinated with the recommended two shots, after indications that vaccine protection against severe illness has waned.
The booster shot reduced the risk of infection in the 60-plus age group by 86% and against severe infection by 92%, according to an observational study by Israel’s second largest healthcare provider, Maccabi Health Services, released Wednesday. ...
Comments
Updated findings: Israel's ministry confirms booster analysis